Insiders / Kenney Christopher John

Kenney Christopher John

CIK 1880129personinsider
Companies
1
First seen
Jan 9, 2026
Last activity
Mar 13, 2026
CompanyRoleShares heldPeak heldTradesLatest
Xenon Pharmaceuticals Inc. · XENEExecutive7,069100,0009—

All securities held

3 positions · latest reported per filing
CompanySecuritySharesAs of
Xenon Pharmaceuticals Inc.Common Shares7,069Mar 13, 2026
Xenon Pharmaceuticals Inc.Share Option (Right to Buy)Derivative100,000Jan 9, 2026
Xenon Pharmaceuticals Inc.Restricted Share UnitsDerivative11,250Mar 12, 2026
InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Mar 10, 2026SellXENE
Xenon Pharmaceuticals Inc.
Common Shares
$166.6K-3K
-36.95%
4,729
<0.01% of shares
medium
Mar 13, 2026SellXENE
Xenon Pharmaceuticals Inc.
Common Shares
$77.9K-1K
-16.63%
7,069
<0.01% of shares
low
Mar 12, 2026ExerciseXENE
Xenon Pharmaceuticals Inc.
Restricted Share Units
—-4K
-25.00%
11,250
0.01% of shares
low
Mar 12, 2026ExerciseXENE
Xenon Pharmaceuticals Inc.
Common Shares
—+4K
+79.30%
8,479
<0.01% of shares
low
Mar 9, 2026ExerciseXENE
Xenon Pharmaceuticals Inc.
Performance Share Units
—-8K
-100.00%
0
0.00% of shares
low
Mar 9, 2026GrantXENE
Xenon Pharmaceuticals Inc.
Performance Share Units
—+8K
7,500
<0.01% of shares
low
Mar 9, 2026ExerciseXENE
Xenon Pharmaceuticals Inc.
Common Shares
—+8K
7,500
<0.01% of shares
low
Jan 9, 2026GrantXENE
Xenon Pharmaceuticals Inc.
Restricted Share Units
—+20K
20,000
0.02% of shares
low
Jan 9, 2026GrantXENE
Xenon Pharmaceuticals Inc.
Share Option (Right to Buy)
—+100K
100,000
0.10% of shares
low